Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Eastgate Biotech Corp. (ETBI)

Total paid for Promotions this month: $1,000
E-mails this Month: 1
Estimated Volume Generated: $0
Research Report on ETBI: Click to see
* The information presented is based on information for Apr , 2016
Good Afternoon, New Trade Alert: Eastgate Biotech Corp. (OTCPINK: ETBI) Get ready because I have found a biotech trade idea that I believe can provide you with substantial upside opportunity owing to its bullish chart setup. I believe you should give it your undivided attention. ETBI is an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel ...read more
Promoter: HSP Team Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $1,000 UNKNOWN
Max Profit: 33.33 % Gain at close: Pending
    View this email in your browser       EastGate Biotech; This little company is making the next big pill By: Derek McCarthy, INS consulting LLC Just to make this interesting I wanted to paint a picture for you so you understand the gravity of impact of diabetes in America. EastGate Bio Tech -ETBI can change the treatment methodology and actually ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $4,000 UNKNOWN
Max Profit: 14.67 % Gain at close: Pending
    View this email in your browser       Eastgate BiotechEastGate Biotech produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. We utilize state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $4,000 UNKNOWN
Max Profit: 14.67 % Gain at close: Pending

ETBI Jan 28, 2016 22:01

    View this email in your browser     *ETBI* has seen huge accumulation over the past two weeks and will continue to run towards .05 cents. Check out why this company is extremely undervalued. The future of this company rests with its proprietary delivery system of daily medications as a non-evasive form to replace insulin shots as a tablet. A little dissolvable ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $4,000 UNKNOWN
Max Profit: 14.67 % Gain at close: Pending

ETBI Jan 28, 2016 21:12

  New Alert : *ETBI*- EastGate BioTech I'd like to bring your attention today to a company that has revolutionized that way our family members are able to receive insulin as diabetic patients. This Company has seen huge accumulation over the past two weeks and will continue to run towards .05 cents.  The future of this ...read more
Promoter: TopStockTips Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI Unknown compensation UNKNOWN
Max Profit: 14.67 % Gain at close: Pending
    View this email in your browser         EastGate Biotech Receives Notice of Publication From the US Patent and Trademark Office for Two Patents for the Company's Proprietary Intraoral Lorazepam Spray[Marketwired] EastGate Biotech Corp. 6 minutes ago   Content preferencesDone Related Quotes ETBI0.03490.00% Eastgate Biotech Corp. ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $2,000 UNKNOWN
Max Profit: 24.39 % Gain at close: Pending
    View this email in your browser         This is a great articel explaining the biotech that is coming out of $ETBI-EastGate Bio which is out number one pick since last week. THe stock has gone from .012 to .0345 and is getting alot more attention. Dr. Jones explains some of the benifits that $ETBI is providing with their treatments. info@docgiff.comThe ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $2,000 UNKNOWN
Max Profit: 24.39 % Gain at close: Pending
    View this email in your browser         Good morning team, happy Monday! Today we are still talking about ETBI which was up 175% last week after we started to cover it. Also we are happy to hear that ACOL was also up about 40%. I love these plays and want you guys to do some home work on them ASAP. Heres some news from last week on ETBI to help ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $2,000 UNKNOWN
Max Profit: 24.39 % Gain at close: Pending
    View this email in your browser         Good morning team, happy Monday! Today we are still talking about ETBI which was up 175% last week after we started to cover it. Also we are happy to hear that ACOL was also up about 40%. I love these plays and want you guys to do some home work on them ASAP. Heres some news from last week on ETBI to help ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $2,000 UNKNOWN
Max Profit: 24.39 % Gain at close: Pending
    View this email in your browser         We are proud to announce that ETBI is a new client. Like ACOL in the past we are commited to a long term relationship with EastGate Bio-ETBI and hope that you , as the network find the story of this company as compelling as we do. Happy trading in 2016! SALT LAKE CITY, UT and TORONTO, ON--(Marketwired ...read more
Promoter: Investor News Source Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
ETBI $2,000 UNKNOWN
Max Profit: 24.39 % Gain at close: Pending
First  >> Last